⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Phase 2 Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Subjects With Indolent Non-Hodgkin Lymphoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Phase 2 Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Subjects With Indolent Non-Hodgkin Lymphoma

Official Title: A Phase 2, Randomized, Open-label, 2-Arm Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Subjects With Indolent Non-Hodgkin Lymphoma (iNHL)

Study ID: NCT04038359

Interventions

Duvelisib

Study Description

Brief Summary: This study will examine the effects of predefined 2-week duvelisib dose holidays on tumor responses and safety/tolerability.

Detailed Description: This is a Phase 2, randomized, open-label, 2-arm study designed to evaluate the efficacy and safety of prescribed drug holidays of duvelisib treatment in subjects with R/R iNHL who have received at least 1 prior systemic therapy.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Florida Cancer Specialists - Fort Myers, Fort Myers, Florida, United States

Florida Cancer Specialists & Research Institute - Lecanto, Lecanto, Florida, United States

Mid-Florida Cancer Centers, Orange City, Florida, United States

Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois, United States

Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States

Tennessee Oncology, Nashville, Tennessee, United States

FN Hradec Kralove, Hradec Králové, , Czechia

Vseobecna fakultni nemocnice v Praze, Praha 2, , Czechia

Universitaetsklinikum Bonn AöR, Bonn, , Germany

Oncology Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Forli, Italy

IEO - Istituto Europeo di Oncologia, IRCCS, Milano, , Italy

AUSL di Reggio Emilia IRCCS, Arcispedale Santa Maria Nuova di Reggio Emilia, Reggio Emilia, , Italy

Azienda Ospedaliera Santa Maria di Terni, Terni, , Italy

Ospedale di Circolo, PO Varese, AO Ospedale di Circolo e Fondazione Macchi, Varese, , Italy

Seoul National University Bundang Hospital, Seongnam-si, , Korea, Republic of

Seoul National University Hospital, Seoul, , Korea, Republic of

Severance Hospital, Yonsei University Health System, Seoul, , Korea, Republic of

Asan Medical Center - Oncology, Seoul, , Korea, Republic of

Samsung Medical Center - Hematology-Oncology, Seoul, , Korea, Republic of

Wojewodzki Szpital Specjalistyczny im. Janusza Korczaka w Slupsku Sp. z o.o., Slupsk, Pomorskie, Poland

Pratia Onkologia Katowice, Katowice, , Poland

Centrum Medyczne Pratia Poznan, Skórzewo, , Poland

State Budgetary Healthcare Institution of Moscow City Moscow Multidisciplinary Clinical Center "Kommunarka" of the Department of Healthcare of Moscow City, Moscow, , Russian Federation

City Clinical Hospital n.a. Botkin, Moscow, , Russian Federation

First Saint-Petersburg State Medical University n.a. I.P. Pavlov, Sankt-Peterburg, , Russian Federation

NHS Greater Glasgow & Clyde - CRUK Clinical Trials Unit, Glasgow, , United Kingdom

Royal Liverpool Hospital [Hematology/Transfusion Medicine], Liverpool, , United Kingdom

Christie Hospital NHS Foundation Trust, Manchester, , United Kingdom

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: